D-tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity

ChemBioChem

Volumn 4, Issue 2-3, 2003, Pages 181-185

  Hansford, Karl A ^a   Reid, Robert C ^a   Clark, Chris I ^a   Tyndall, Joel D A ^a   Whitehouse, Michael W ^a   Guthrie, Tom ^a   McGeary, Ross P ^a   Schafer, Karl ^a   Martin, Jennifer L ^a   Fairlie, David P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Enzymes; Inflammation; Inhibitors; Medicinal chemistry; Structure activity relationships

Indexed keywords

PHOSPHOLIPASE A2 INHIBITOR; TYROSINE;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; CHIRALITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; EDEMA; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALIA;

EID: 0037416464     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbic.200390029     Document Type: Article

References (50)

1. a) D. A. Six, E. A. Dennis, Biochim. Biophys. Acta 2000, 1488, 1-19;
2. b) W. Cho, Biochim. Biophys. Acta 2000, 1488, 48-58;
3. c) Y. Chen, E. A. Dennis, Biochim. Biophys. Acta 1998, 1394, 57-64;
4. d) K. Maxey, J. MacDonald, Cayman Chemicals 1998, 8, 1-5;
5. e) IUPAC-IUB Commission on Biochemical Nomenclature, Biochim. Biophys. Acta 1968, 152, 1-9.
6. a) W. Pruzanski, P. Vadas, Immunol. Today 1991, 12, 143-146;
7. b) W. Pruzanski, P. Vadas, J. Browning, J. Lipid Mediators 1993, 8, 161-167;
8. c) N. Fox, M. Song, J. Schrementi, J. D. Sharp, D. L. White, D. W. Snyder, L. W. Hartley, D. G. Carlson, N. J. Bach, R. D. Dillard, S. E. Draheim, J. L. Bobbitt, L. Fisher, E. D. Mihelich, Eur. J. Pharm. 1996, 308, 195-203, and references therein.
9. D. L. Scott, S. P. White, Z. Otwinowski, W. Yuan, M. H. Gelb, P. B. Sigler, Science 1990, 250, 1541-1546.
10. M. V. Winstead, J. Balsinde, E. A. Dennis, Biochim. Biophys. Acta 2000, 1488, 28-39.
11. F. Bartoli, H. K. Lin, F. Ghomashchi, M. H. Gelb, M. K. Jain, R. Apitz-Castro, J. Biol. Chem. 1994, 269, 15625-15630.
12. J. Balsinde, M. A. Balboa, E. A. Dennis, Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 7951-7956.
13. M. Murakami, S. Shimbara, T. Kambe, H. Kuwata, M. V. Winstead, J. A. Tischfield, I. Kudo, J. Biol. Chem. 1998, 273, 14411-14423.
14. M. Murakami, Y. Nakatani, G. Atsumi, K. Inoue, I. Kudo, Crit. Rev. Immunol. 1997, 17, 225-284.
15. R. M. Kramer, C. Hession, B. Johanson, G. Hayes, P. McGray, E. P. Chow, R. Tizard, R. B. Pepinsky, J. Biol. Chem. 1989, 264, 5768-5775.
16. M. D. Rosenthal, M. N. Gordon, E. S. Buescher, J. H. Slusser, L. K. Harris, R. C. Franson, Biochem. Biophys. Res. Commun. 1995, 208, 650-656.
17. S. P. Chock, E. A. Schmauder-Chock, E. Cordella-Miele, L. Miele, A. B. Mukherjee, Biochem. J. 1994, 300, 619-622.
18. D. L. Scott, S. P. White, J. L. Browning, J. J. Rosa, M. H. Gelb, P. B. Sigler, Science 1991, 254, 1007-1010.
19. J. S. Bomalaski, P. Lawton, J. L. Browning, J. Immunol. 1991, 146, 3904-3910.
20. a) J. Balsinde, M. A. Balboa, P. A. Insel, E. A. Dennis, Annu. Rev. Pharmacol. Toxicol. 1999, 39, 175-189;
21. b) C. I. Clark, R. C. Reid, R. P. McGeary, K. Schafer, D. P. Fairlie, Biochem. Biophys. Res. Comm. 2000, 274, 831-834.
22. L. Arbibe, D. Vial, I. Rosinski-Chupin, N. Havet, M. Huerre, B. B. Vargaftig, L. Touqui, J. Immunol. 1997, 159, 391-400;
23. a) D. W. Snyder, N. J. Bach, R. D. Dillard, S. E. Draheim, D. G. Carlson, N. Fox, N. W. Roehm, C. T. Armstrong, C. H. Chang, L. W. Hartley, L. M. Johnson, C. R. Roman, A. C. Smith, M. Song, J. H. Fleisch, J. Pharmacol. Exp. Ther. 1999, 288, 1117-1124;
24. b) D. M. Springer, Curr. Pharm. Des. 2001, 7, 181-198.
25. c) R. W. Schevitz, N. J. Bach, D. G. Carlson, N. Y. Chirgadze, D. K. Clawson, R. D. Dillard, S. E. Draheim, L. W. Hartley, N. D. Jones, E. D. Mihelich, J. L. Olkowski, D. W. Snyder, C. Sommers, J.-P. Wery, Nat. Struct. Biol. 1995, 2, 458-465.
26. a) S. W. Nahm, S. M. Weinreb, Tetrahedron Lett. 1981, 22, 3815-3818;
27. b) J. A. Dale, D. L. Dull, H. S. Mosher, J. Org. Chem. 1969, 34, 2543-2549;
28. c) Pyridyl- and phenylalkanoic acid derivatives were prepared by Wittig reaction of the appropriate arylaldehyde, as described in the Supporting Information.
29. -1 bovine serum albumin), 5,5′-dithionitrobenzoic acid (Ellman's reagent), ± test inhibitor in dimethyl sulfoxide (5 μL). Mixtures were incubated at 37°C, and enzyme activity was measured by reaction of cleaved thioester substrate with Ellman's reagent, quantified by absorbance at 414 nm. This assay is described in the Cayman Chemicals assay kit handbook (http://www.caymanchem.-com/index.html) and in: L. J. Reynolds, L. L. Hughes, E. A. Dennis, Anal. Biochem. 1992, 204, 190-197.
30. A. Dessen, J. Tang, H. Schmidt, M. Stahl, J. D. Clark, J. Seehra, W. S. Somers, Cell 1999, 97, 349-360.
31. M. M. G. M. Thunnissen, A. B. Eiso, K. H. Kalk, J. Drenth, B. W. Dijkstra, O. P. Kuipers, R. Dijkman, G. H. Dehaas, H. M. E. Verheij, Nature 1990, 347, 689-691.
32. B.-H. Oh, Acta Crystallogr. 1995, D51, 140-144.
33. M. T. Pisabarro, A. R. Ortiz, A. Palomer, F. Cabre, L. Garcia, R. C. Wade, F. Gago, D. Mauleon, G. Carganico, J. Med. Chem. 1994, 37, 337-341.
34. S.-S. Cha, D. Lee, J. Adams, J. T. Kurdyla, C. S. Jones, L. A. Marshall, B. Bolognese, S. S. Abdel-Meguid, B.-H. Oh, J. Med. Chem. 1996, 39, 3878-3881.
35. K. H. Kitadokoro, S. Hagishita, T. Sato, M. Ohtani, K. Miki, J. Biochem. 1998, 123, 619-623.
36. M. D. Bryant, K. E. Flick, R. S. Koduri, D. C. Wilton, B. L. Stoddard, M. H. Gelb, Bioorg. Med. Chem. Lett. 1999, 9, 1097-1102.
37. Y. H. Pan, B.-Z. Yu, A. G. Singer, F. Ghomashchi, G. Lambeau, M. H. Gelb, M. K. Jain, B. Bahnson, J. Biol. Chem. 2002, 277, 29086-29093.
38. 1) with two molecules per asymmetric unit. The two complexes are related by almost perfect noncrystallographic twofold symmetry, spoiled only by the disorder in the inhibitor. Two conformations of the inhibitor were built by assuming that the inhibitor occupies one or other of these spaces at any one time.
39. L. Yu, E. A. Dennis, Proc. Natl. Acad. Sci. U.S.A 1991, 88, 9325-9329.
40. H. G. Beaton, C. Bennion, S. Connolly, A. R. Cook, N. P. Gensmantel, C. Hallam, K. Hardy, B. Hitchin, C. G. Jackson, D. H. Robinson, J. Med. Chem. 1994, 37, 557-559.
41. a) G.B. McGaughey, M. Gagne, A. K. Rappe, J. Biol. Chem. 1998, 273, 15458-15463;
42. b) U. Samanta, P. Debnath, P. Chakrabarti, Acta Crystallogr. 1999, D55, 1421-1427;
43. c) E. Kim, S. Paliwal, C. S. Wilcox, J. Am. Chem. Soc. 1998, 120, 11192-11193;
44. d) K. N. Nakamura, Org. Lett. 1999, 1, 2049-2051;
45. e) S. Paliwal, S. Geib, C. S. Wilcox, J. Am. Chem. Soc. 1994, 116, 4497-4498;
46. f) A. Matsushima, T. Fujita, T. Nose, Y. Shimohigashi, J. Biochem. (Tokyo, Jpn.) 2000, 128, 225-232.
47. M. W. Whitehouse, "Adjuvant-induced polyarthritis in rats" in Handbook of Animal Models for the Rheumatic Diseases (Eds.: R. A. Greenwald, H. S. Diamond), CRC Press, Vol. 1, 3-16.
48. M. K. Lin, A. Katz, H. van den Bosch, B. Kennedy, E. Stefanski, P. Vadas, W. Pruzanski, Inflammation 1998, 22, 161-173.
49. a) E. L. Kukuy, R. John, M. J. Szabolcs, N. Ma, M. Schuster, P. J. Cannon, D. P. Fairlie, N. M. Edwards, J. Heart Lung Transplant 2002, 21, 133;
50. University of Queensland, Australian patent applications, PQ8965/00, PR1669/00, 2000; international patent application, WO02/081889, 2000.